SRC recommended that the trial escalate to the next dose level of 22mg capsule No dose-limiting toxicities (DLT’s) or rash observed to date in either capsule or tablet formulations MIAMI, Feb. 05, 2025 — Pasithea […]
MCLEAN, Va., January 30, 2025—-BigBear.ai (NYSE: BBAI), a leader in AI-powered decision intelligence for defense and national security, has been awarded a prime Indefinite Delivery/Indefinite Quantity (IDIQ) contract under the U.S. Department of Navy’s SeaPort […]
Buford, GA, Jan. 30, 2025– ScanTech AI Systems, Inc. (NASDAQ: STAI, ScanTech, or ScanTech AI), a security solutions provider offering one of the world’s most advanced non-intrusive “fixed-gantry” CT screening technologies, proudly announced today the […]
SYDNEY, Jan. 30, 2025 — Kazia Therapeutics Limited (NASDAQ: KZIA) an oncology-focused drug development company, is pleased to announce the regulatory approval and launch of a clinical trial evaluating the combination of paxalisib and immunotherapy in […]
CORNELIUS, N.C., Jan. 06, 2025 — Alpha Modus Holdings, Inc. (NASDAQ: AMOD) (“Alpha Modus” or the “Company”), announces a major milestone with the issuance of its 9th patent, further solidifying its position at the forefront […]
CAMARILLO, CA, Jan. 27, 2025 — NEWTON GOLF Company (NASDAQ: SPGC) (“NEWTON GOLF” or the “Company”), a technology-forward golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other […]
Development advancing to verification and testing phase; Aims to future-proof design, lower componentry costs and improve manufacturing ELMSFORD, N.Y., January 07, 2025—-NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, […]
NEW YORK, Dec. 26, 2024 — Nvni Group Limited (NASDAQ: NVNI) (“Nuvini” or the “Company”), the leading serial acquirer of private SaaS B2B companies in Latin America reports financial results for FY 2023: Key highlights: […]
Northstrive Biosciences Inc. was invited to present EL-22, a novel myostatin asset aimed at preserving muscle while on weight loss treatments, at the UCLA Obesity Symposium called Anti-Obesity Treatments: Challenges and Emerging Solutions, organized by […]
Banzai Adds Enterprise Marketing Automation Platform, the Cornerstone of AI-driven B2B Marketing, to Growing Product Family SEATTLE, Jan. 23, 2025 — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that […]
WESTBOROUGH, Mass., January 21, 2025–(BUSINESS WIRE)–Kopin Corporation (NASDAQ: KOPN) a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, will be exhibiting at SPIE AR/VR/MR 2025, […]
EDISON, N.J., Jan. 22, 2025 — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, announced the […]
This new collaboration was driven by the successful fast tracking of joint projects in Germany and Italy follows the recently signed three-way clean energy cooperation agreement between Italy, Albania, and the United Arab Emirates Neve Yarak, Israel, […]
MIAMI, FL AND LONDON, UK / December 24, 2024 / MGO Global Inc. (NASDAQ:MGOL), a digitally-native, lifestyle brand portfolio company, (“MGO,” “MGO Global” or the “Company”), today announced the closing of its previously announced public […]
BROOMFIELD, CO – January 17, 2025 – Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
